ABSCIENCES (EPA:AB) AB Science announces that it has received a second authorization to resume patient enrollment, in the Phase 3 study of masitinib in mastocytosis
Transparency directive : regulatory news
25/08/2021 18:46
ABSCIENCES's latest news
13/03/2024 12:58
07/03/2024 15:20
06/03/2024 20:21
29/02/2024 11:49
26/02/2024 18:32
28/11/2023 19:22
27/11/2023 08:04
29/09/2023 19:49
18/09/2023 18:05
01/06/2023 18:01
Other stories
23/04/2024 23:26
24/04/2024 04:36
24/04/2024 03:30
24/04/2024 03:22
24/04/2024 04:57
23/04/2024 17:27
24/04/2024 02:08
23/04/2024 22:35
23/04/2024 19:57
23/04/2024 18:08
23/04/2024 23:38
24/04/2024 03:01
23/04/2024 23:17
23/04/2024 23:15
24/04/2024 02:05
23/04/2024 17:21
23/04/2024 17:48
23/04/2024 18:03
23/04/2024 06:14
23/04/2024 19:32
22/04/2024 23:45
23/04/2024 08:34
23/04/2024 23:00
24/04/2024 01:18
24/04/2024 02:07
23/04/2024 20:01
24/04/2024 03:30
23/04/2024 21:07
23/04/2024 23:30
Erik ten Hag should have followed Fergie's example but Man Utd boss buried head in sand - The Mirror
23/04/2024 21:19
23/04/2024 19:00
24/04/2024 01:01
22/04/2024 18:16
22/04/2024 21:46
23/04/2024 20:17
24/04/2024 03:26
24/04/2024 02:18
23/04/2024 03:16